CertifyOS launched Provider Hub, an AI-powered platform that helps payers unify provider data and reduce administrative costs. The post CertifyOS Unveils Provider Data Platform to Streamline Operations and Cut Costs appeared first on MedCity News.
Hours into the federal government shutdown, Julio Fuentes stood steps from the U.S. Capitol to deliver an urgent message about the Hispanic voting bloc that helped the GOP sweep into power last year. Those votes, he cautioned, are at risk if Congress doesn’t pass a law to preserve lower premiums on Affordable Care Act marketplace…
While Skye Bioscience said its drug nimacimab may yet achieve better weight loss results with higher doses, the company and analysts are interested in the drug’s potential to be combined with Novo Nordisk’s Wegovy. Skye’s drug is an antibody designed to preferentially target CB1 receptors in the gut, offering an alternative approach to activating GLP-1…
Horas después del cierre del gobierno federal, Julio Fuentes se encontraba a pocos pasos del Capitolio de Estados Unidos para transmitir un mensaje urgente sobre el bloque de votantes hispanos que ayudó al Partido Republicano a llegar al poder el año pasado. Esos votos, advirtió, están en riesgo si el Congreso no aprueba una ley…
Relentlessly, rates of chronic disease, depression, and medication use continue to rise — if there were ever a time to implement alternative preventive health tools in clinical practice, now is certainly it. The post Steps or Surgery: The Case for Wearables appeared first on MedCity News.
Relentlessly, rates of chronic disease, depression, and medication use continue to rise — if there were ever a time to implement alternative preventive health tools in clinical practice, now is certainly it. The post Steps or Surgery: The Case for Wearables appeared first on MedCity News.
The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions. The post The Tariff Opportunity for Medtech: Building the Supply Chain…
The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions. The post The Tariff Opportunity for Medtech: Building the Supply Chain…
Because states have flexibility in designing their programs, state Medicaid spending and enrollment varies across states. This data note provides an overview of total Medicaid spending per enrollee by eligibility group and state.
Because states have flexibility in designing their programs, state Medicaid spending and enrollment varies across states. This data note provides an overview of total Medicaid spending per enrollee by eligibility group and state.